Journal of Clinical Virology
Volume 46, Issue 2 , Pages 105-106 , October 2009

Facial rash in a pregnant woman

  • Sheila Waugh

      Affiliations

    • Department of Microbiology, Freeman hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne NE4 6BE, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 0191 244 8948; fax: +44 0191 223 1224.
    • ,
  • Kevin E. Brown

      Affiliations

    • Virus Reference Department, Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London NW9 5EQ, UK

References 

  1. Anderson MJ, Jones SE, Fisher-Hoch SP, Lewis E, Hall SM, Bartlett CLR, et al. Human parvovirus, the cause of erythema infectiosum (fifth disease)?. Lancet. 1983;i:1378;[letter]
  2. Anderson MJ, Davis LR, Jones SE, Pattison JR, Serjeant GR. The development and use of an antibody capture radioimmunoassay for specific IgM to a human parvovirus-like agent. J Hyg (Lond). 1982;88:309–324
  3. Thomas HI, Barrett E, Hesketh LM, Wynne A, Morgan-Capner P. Simultaneous IgM reactivity by EIA against more than one virus in measles, parvovirus B19 and rubella infection. J Clin Virol. 1999;14:107–118
  4. Enders M, Weidner A, Rosenthal T, Baisch C, Hedman L, Soderlund-Venermo M, et al. Improved diagnosis of gestational parvovirus B19 infection at the time of nonimmune fetal hydrops. J Infect Dis. 2008;197:58–62
  5. Manaresi E, Gallinella G, Zuffi E, Bonvicini F, Zerbini M, Musiani M. Diagnosis and quantitative evaluation of parvovirus B19 infections by real-time PCR in the clinical laboratory. J Med Virol. 2002;67:275–281
  6. Kleinman SH, Glynn SA, Lee TH, Tobler L, Montalvo L, Todd D, et al. Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay. Transfusion. 2007;47:1756–1764
  7. Norja P, Hokynar K, Aaltonen LM, Chen R, Ranki A, Partio EK, et al. Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci USA. 2006;103:7450–7453
  8. Miller E, Fairley CK, Cohen BJ, Seng C. Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol. 1998;105:174–178
  9. Brown KE, Green SW, Antunez de Mayolo J, Bellanti JA, Smith SD, Smith TJ, et al. Congenital anaemia after transplacental B19 parvovirus infection. Lancet. 1994;343:895–896
  10. Morgan-Capner P, Crowcroft NS. Guidelines on the management of, and exposure to, rash illness in pregnancy (including consideration of relevant antibody screening programmes in pregnancy). Commun Dis Public Health. 2002;5:59–71
  11. Hartwig NG, Vermeij-Keers C, van Elsacker-Niele AM, Fleuren GJ. Embryonic malformations in a case of intrauterine parvovirus B19 infection. Teratology. 1989;39:295–302

PII: S1386-6532(09)00378-3

doi: 10.1016/j.jcv.2009.08.001

Journal of Clinical Virology
Volume 46, Issue 2 , Pages 105-106 , October 2009

Article Tools